Tech / Reel
Tech · Video brief
AI isn’t close to curing cancer. This startup says it knows what it will take.
Vivodyne asserts that the AI drug-discovery sector needs enhanced data to truly advance. With their innovative HIVE robotic labs, they focus on growing human tissues to improve AI models, aiming for more accurate predictive outcomes for dru...
Video won't play? Watch on YouTube →
Vivodyne asserts that the AI drug-discovery sector needs enhanced data to truly advance. With their innovative HIVE robotic labs, they focus on growing human tissues to improve AI models, aiming for more accurate predictive outcomes for drug approvals. Full story and more reels: https://newsreel.video #news #AI #biotech #cancerresearch #drugdiscovery #innovation
Originally reported by TechCrunch.
Read the full story →
More in Tech
Tech
Tech
Tech
Meta’s Oversight Board has a warning for AI companies building their own watchdogs
Tech
Tech
Tech
Stop worrying about my AI, says multibillionaire Sam Altman. So we bear the risks and he keeps the money | Chris Stokel-Walker
Tech
Tech
Tech
0 Comments
No comments yet. Be the first.